RenovoRx Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $10M
Latest Deal Amount
  • Investors
  • 15

RenovoRx General Information

Description

Developer of medical catheters designed to provide targeted delivery of therapeutics to selected sites in the peripheral vascular system. The company's medical catheter RenovoCath has the ability to deliver fluid materials at high concentration to specific vasculature, safely and without perfusion overlap to other regions, enabling physicians to treat their patients with direct and localized delivery of fluids to the peripheral vessels.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • 4546 El Camino Real
  • Suite 223
  • Los Altos, CA 94022
  • United States
+1 (650) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RenovoRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series D) 23-May-2018 $10M 000.00 0000 Completed Generating Revenue
5. Later Stage VC (Series C) 14-Dec-2015 00.00 00.00 000.00 Completed Generating Revenue
4. Accelerator/Incubator 19-Nov-2015 00.00 Completed Generating Revenue
3. Early Stage VC (Series B) 27-Jan-2014 00.000 00.00 00.000 Completed Startup
2. Early Stage VC (Series A) 10-Apr-2013 $660K $660K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view RenovoRx’s complete valuation and funding history, request access »

RenovoRx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00 00.0 00.0 00 00.0 000
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 3,546,095 $0.000100 6% $0.32 $0.32 1x $0.32 9.78%
Series A 3,542,669 $0.000100 6% $0.19 $0.19 1x $0.19 9.77%
To view RenovoRx’s complete cap table history, request access »

RenovoRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of medical catheters designed to provide targeted delivery of therapeutics to selected sites in the peripheral
Surgical Devices
Los Altos, CA
4 As of 2014
000.00
000 0000-00-00
00000000000 000.00

00000000

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore ma
00000000 0000000
Mason, OH
000 As of 0000
0000
0000 0000-00-00
00000000 0000

00000000

it amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna ali
00000000 0000000
Marlborough, MA
00 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RenovoRx Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Atricure Formerly VC-backed Mason, OH 000 0000 00000000 0000
00000000000 Venture Capital-Backed Marlborough, MA 00 00000 000000 - 000 00000
000000000000 00000 Angel-Backed Syracuse, NY 00.000 0000000000 00.000
00000000 00000000 Private Equity-Backed Antioch, TN 000 000.00 000000000 000.00
00000000 0000000 0 Corporate Backed or Acquired Draper, UT 000000&0
You’re viewing 5 of 20 competitors. Get the full list »

RenovoRx Executive Team (12)

Name Title Board Seat Contact Info
Shaun Bagai Chief Executive Officer & Board Member
Kamran Najmabadi Co-Founder, Chief Technology Officer, Chief Operating Officer & Technical Engineering Advisor
Ramtin Agah MD Co-Founder, Chief Medical Officer & Board Member
Joost de Schutter Vice President, Finance
Andrew Stack Director, Information Technology and Clinical Data Management
You’re viewing 5 of 12 executive team members. Get the full list »

RenovoRx Board Members (9)

Name Representing Role Since
K. Angela Macfarlane JD Self Board Member 000 0000
Klaus Hambuechen The Angels' Forum Board Member 000 0000
Laurence Marton MD Self Board Member 000 0000
Ramtin Agah MD RenovoRx Co-Founder, Chief Medical Officer & Board Member 000 0000
Shaun Bagai RenovoRx Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

RenovoRx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RenovoRx Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Acorn Campus Taiwan Venture Capital Minority 000 0000 000000 0
Boston Scientific Ventures Corporate Venture Capital Minority 000 0000 000000 0
b-to-v Partners Venture Capital Minority 000 0000 000000 0
Next Wave Impact Venture Capital Minority 000 0000 000000 0
Portfolia Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »